BOT — Botanix Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$32.81m
- AU$8.12m
- AU$33.80m
Annual cashflow statement for Botanix Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.79 | 3.73 | 0.076 | 3.38 | 1.11 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.2 | -12.1 | -8.13 | -78.6 | -64.6 |
| Capital Expenditures | -2.92 | -7.05 | -18 | -1.05 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | -0.409 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.92 | -7.05 | -18 | -1.05 | -0.409 |
| Financing Cash Flow Items | — | -1.44 | -5.76 | -3.31 | -5.42 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.152 | 22 | 95.1 | 65.4 | 36.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -14.3 | 2.96 | 69.1 | -14.3 | -28.3 |